Rachel A Walz, CNS in Olivia, MN - Clinical Nurse Specialist

Rachel A Walz, CNS is a Clinical Nurse Specialist - Adult Health based in Olivia, Minnesota. Rachel A Walz is licensed to practice in Minnesota (license number 2008004437) and her current practice location is 611 E Fairview Ave, Olivia, Minnesota. She can be reached at her office (for appointments etc.) via phone at (320) 523-1261.

NPI number for Rachel A Walz is 1346480464 and her current mailing address is 611 E Fairview Ave, Olivia, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346480464.

Contact Information

	Rachel A Walz, CNS
	611 E Fairview Ave, Olivia, MN 56277-4213
	(320) 523-1261
	Not Available

Provider's Profile

Full Name	Rachel A Walz
Gender	Female
Speciality	Clinical Nurse Specialist - Adult Health
Location	611 E Fairview Ave, Olivia, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1346480464
Provider Enumeration Date: 03/02/2009
Last Update Date: 03/02/2009

Medical Identifiers

Medical identifiers for Rachel A Walz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346480464	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SA2200X	Clinical Nurse Specialist - Adult Health	2008004437 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rachel A Walz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Rachel A Walz, CNS 611 E Fairview Ave, Olivia, MN 56277-4213 Ph: (320) 523-1261	Rachel A Walz, CNS 611 E Fairview Ave, Olivia, MN 56277-4213 Ph: (320) 523-1261

News Archive

Survey finds shortage of TB medicines in U.S.; Consequences similar to lack of access in developing countries, advocate says

"More than 80 percent of health departments in the United States that treat tuberculosis [TB] resistant to standard treatment have trouble obtaining the drugs they need to cure the disease, according to a national survey released on Thursday," Reuters reports.

Research finds rise in number of New Hampshire infants diagnosed with NAS

From 2005 to 2015 the number of infants diagnosed with neonatal abstinence syndrome (NAS) in the Granite State increased fivefold, from 52 to 269, according to new research by the Carsey School of Public Policy at the University of New Hampshire.

Pre-clinical data for Celltrion's antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19.

New therapeutic treatment may provide a potential alternative to bone grafting operation

A study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.

BMA Scotland comment on the publication of the Patient Rights

"BMA Scotland supports the Scottish Government's aim to encourage a stronger sense of public ownership of the NHS and the renewed commitment to provide a service which is publicly funded and owned, free at the point of delivery. As such, we welcome the commitment to articulate the rights and responsibilities of all those using and providing NHS services.

Rachel A Walz, CNS - Clinical Nurse Specialist in Olivia, MN